Arcutis Biotherapeutics, Inc. ARQT Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s cash ratio?
- Arcutis Biotherapeutics, Inc. (ARQT) reported cash ratio of 0.2× in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s cash ratio changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s cash ratio decreased by 63.5% year-over-year, from 0.6× to 0.2×.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s cash ratio has grown at a -35.4% compound annual growth rate (CAGR), from 2.9× to 0.3×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.